The number of reported human cases of illness caused by Campylobacter and Salmonella bacteria across Europe appears to have stabilised over the past five years, according to the latest report on zoonotic diseases by EFSA and ECDC.
This report of the EFSA and ECDC presents the results of zoonoses monitoring activities carried out in 2019 in 36 European countries (28 Member States (MS) and eight non-MS).
Urgent action is required to improve efforts to prevent hepatitis B and C infections in the EU/EEA and the UK if the region is to meet the 2020 targets for the elimination of viral hepatitis as a serious threat to public health. Significant gaps in the reported data in relation to prevalence and prevention of HBV and HCV in EU/EEA and the UK present a major challenge to monitoring progress towards the targets for elimination of hepatitis.
This report presents the results of the fourth round of the EQA on antimicrobial susceptibility testing (AST) for national public health laboratories for Campylobacter (Campylobacter EQA4-AST) within the Food‐ and Waterborne Diseases and Zoonoses Network (FWD-Net). The objectives of this EQA4-AST were to determine the accuracy of quantitative AST results reported by participants; to identify common laboratory problems related to the guidance in the EU protocol, and to assess the overall comparability of routinely collected AST data from national public health reference laboratories across Europe.
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 11-17 October 2020 and includes updates on COVID-19 associated with SARS-CoV-2, malaria, West Nile virus, influenza, Ebola virus disease - eleventh outbreak in the Democratic Republic of the Congo and Poliomyelitis.